January 4, 2013
The most comprehensive retrospective study ever conducted comparing how the major types of prostate cancer treatments stack up to each other in terms of saving lives and cost effectiveness is reported this week by a team of researchers at UCSF.
December 20, 2012
UCSF is a health-sciences research powerhouse – a premier academic medical center that values not only the physician who designs clinical trial protocols for promising experimental drugs, but also the talented lab scientist who unearths nature’s secrets on the molecular and cellular levels.
December 19, 2012
As the year comes to a close, HDFCCC director Frank McCormick extends a thank you to our donors for a year of philanthropy.
December 18, 2012
VIDEO: View the UCSF Helen Diller Family Comprehensive Cancer Center Showcase 2012 opening plenary session.
December 17, 2012
Drugs and medical devices tend to appear more beneficial in scientific papers if they were manufactured by the company that sponsored the study, showing that who pays for the clinical trial has a direct impact on the reported outcome, according to a new analysis by researchers at UCSF and the Cochrane Collaboration.
December 13, 2012
St. Joseph's Medical Center is bringing advanced cancer care to San Joaquin County with a new collaboration between St. Joseph's Regional Cancer Center and the UCSF Helen Diller Family Comprehensive Cancer Center that will enhance patient care and access to clinical trials.
December 12, 2012
The pelvic exam, a standard part of a woman's gynecologic checkup, frequently is performed for reasons that are medically unjustified, according to the authors of a UCSF study that may lay the groundwork for future changes to medical practice.
December 11, 2012
President Barack Obama announced his intent to nominate UCSF's Mack Roach III, MD, FACR, an internationally recognized expert on using radiation to treat and manage prostate cancer, to the National Cancer Advisory Board.
December 6, 2012
Precision medicine and cancer genetics were among the topics discussed during 11 breakout sessions guided by 30 UCSF faculty members at the Nov. 7 showcase for the UCSF Helen Diller Family Comprehensive Cancer Center.
December 6, 2012
The rate of cancer survival is expected to keep climbing in coming years largely thanks to research discoveries that are translating into new cancer drugs, which currently account for roughly 30 percent of the pharmaceutical dollar, the chief scientific officer at Bristol-Myers Squib recently said at a showcase event for the UCSF Helen Diller Family Comprehensive Cancer Center.